விவோ மூலதனம் நிதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from விவோ மூலதனம் நிதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In விவோ மூலதனம் நிதி Today - Breaking & Trending Today

Editor's take: The Week That Was — Aug 2-7

Editor's take: The Week That Was — Aug 2-7
dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.

New York , United States , United Kingdom , Saint Michael , South Korea , South Korean , Warung Pintar , Warburg Pincus , Asia Pacific , Agung Bezharie , Peter Thiel , Richard Li , Straits Trading Company , Asia Opportunity Fund , Indonesia Stock Exchange , Capital Group , Emtek Group , Cayman Ltd , Vivo Capital Fund , Bridgetown Holdings , Softbank Vision Fund , Tencent Holdings , Korea Sk Group , Sequoia Capital , Prosus Ventures , Lightspeed Venture Partners ,

New Frontier receives proposal to go private in nearly $1.72 billion deal

By Reuters Staff
2 Min Read
(Reuters) - New Frontier Health Corp said on Wednesday it received an offer to be bought out by a consortium of investors in a deal that values the healthcare service provider at nearly $1.72 billion.
The company said in a statement it received a preliminary non-proposal binding letter from a buyer-group, including President Carl Wu, Carnival Investments, Vivo Capital Fund IX, Max Rising International Ltd, a company affiliated with Carl Wu, among others to “go private”.
The group offered to acquire outstanding shares of New Frontier Health, which operates private hospitals, outpatient clinics and medical centers, for $12 in cash, representing a premium of 23.6% to the company’s closing price on Tuesday. ....

Sherry Jacob Phillips , Carl Wu , Anirudh Saligrama , Thomson Reuters Trust Principles , Max Rising International Ltd , Shanghai Fosun Pharmaceutical Group Co Ltd , Frontier Health , Vivo Capital Fund , Frontier Corp , Frontier Health Corp , Carnival Investments , New Frontier Health , New Frontier Corp , United Family Healthcare , New Frontier , Thomson Reuters Trust , Corporate Events , Banking Amp Investment Services Trbc Level 2 , Content Produced In Bangalore , Company News , Health Medicine , Healthcare Trbc Level 1 , Healthcare Facilities Amp Services Trbc Level 4 , Healthcare Facilities Amp Services Nec Trbc Level 5 , Security Listings Delistings , Mergers Acquisitions Takeovers ,

Serán Bioscience Announces Investment by Vivo Capital

Serán Bioscience Announces Investment by Vivo Capital
A majority investment by Vivo Capital, a healthcare investment firm headquartered in Silicon Valley, will fund the expansion of Serán s service offering, the doubling of clean room capacity by year-end, and the development and construction a new commercial scale cGMP manufacturing facility by the end of 2022.
News provided by
Share this article
Share this article
BEND, Ore., Jan. 6, 2021 /PRNewswire/ Serán Bioscience today announced that healthcare investment firm Vivo Capital has made a majority investment in Serán alongside Serán s founders who will continue to lead the Company.
Founded in 2016, Serán is a leading contract development and manufacturing organization providing a comprehensive suite of development, analytical and clinical manufacturing services to pharmaceutical and biotechnology companies. Serán s deep experience and expertise in materials science, formulation development, ....

United States , Palo Alto , Williamson Wyatt , Latham Watkins , Dan Smithey , John Melvin , Suzanne Brady , Prnewswire Sera , Mahendra Shah , William Blair , B Vivo Capital Fund , M Vivo Opportunity Fund , Business Development , Vivo Capital , Managing Director , Vivo Capital Fund , Vivo Opportunity Fund , Vivo Innovation , ஒன்றுபட்டது மாநிலங்களில் , பாலோ ஆல்டோ , வில்லியம்சன் வையட் , லாதம் வாட்கின்ஸ் , டான் ஸ்மீத்ெய் , ஜான் மெல்வின் , ஸுஸ்யாந் பிராடி , மகேந்திரா ஷா ,

Provivi® raises $45.5M to expand global launch

Provivi Team
Successfully introducing insect pheromones to control damaging pests, the increased funding will strengthen the capacity for a global roll-out
SANTA MONICA, CA, UNITED STATES, December 22, 2020 /EINPresswire.com/ Provivi, Inc. ( Provivi ), an emerging crop protection company using pheromones to protect large acreage row crops from major damaging insects, is pleased to inform the completion of a $45.5M financing round. Vivo Capital, a Palo Alto based investment fund, led the round. Returning shareholders, including Kairos Ventures, Temasek, Pontifax AgTech, Tybourne Capital, Lanx Capital, and Spruce Capital, also participated in the financing.
The Series C-2 financing is a new milestone in the growth of our company. It builds upon a very successful year where Provivi achieved several product registrations worldwide and launched our first product commercially in Mexico, said Dr. Pedro Coelho, Co-Founder and CEO ....

United States , Santa Monica , Palo Alto , Pedro Coelho , Ganesh Kishore , Pontifax Agtech , Shan Fu , B Vivo Capital Fund , Provivi Team , Provivi Inc , M Vivo Opportunity Fund , Kairos Ventures , Tybourne Capital , Lanx Capital , Spruce Capital , Managing Partner , Vivo Capital , Vivo Capital Fund , Vivo Opportunity Fund , Vivo Innovation , ஒன்றுபட்டது மாநிலங்களில் , சாந்தா மோனிகா , பாலோ ஆல்டோ , பேடரோ கோல்ோ , கணேஷ் கிஷோர் , ஷான் ஃபூ ,